Liver Metastatic Disease: 2022 Year in Review Daniel Brown, MD, FSIR reviews noteworthy 2022 studies on liver metastatic disease at the Symposium on Clinical Interventional Oncology. Daniel B. Brown , MD, FSIR; 01/04/2023 HCC: 2022 Year in Review Riad Salem, MD, MBA presents notable studies from 2022 at the Symposium on Clinical Interventional Oncology. Riad Salem , MD, MBA; 01/01/2023 HCC Treatment Complicated by Pneumothorax Ahmed K. Abdel Aal , MD, PhD; 02/17/2022 Biliary Complications After SIRT Alban Denys , MD; 02/16/2022 Extreme IO Cases: HCC Treated With Y-90 and Prostate Cancer With Metastatic Bone Lesion Treated With Ablation and Cementoplasty George Behrens , MD; 02/16/2022 Extreme IO: RFA in a 4-Year-Old Child With Stage IV Hepatoblastoma and Metastatic Lung Cancer Thierry De Baère , MD; 02/16/2022 Extreme IO: Extraordinary Use of a Cardiology Device for Non-Vascular IR Ziv J. Haskal, MD , MD; 02/16/2022 Inadequate Future Liver Remnant: Hepatic Venous Deprivation with Simultaneous Portal Vein Embolization and Hepatic Vein Embolization Alban Denys , MD; 02/08/2022 Technical Pearls Audience Q&A 02/07/2022 Ablation of Poorly Visualized Tumors: My Top 5 Technical Pearls Raul N. Uppot , MD; 02/07/2022 Load More
